BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37940813)

  • 21. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
    de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
    Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
    Barton DL; Burger K; Novotny PJ; Fitch TR; Kohli S; Soori G; Wilwerding MB; Sloan JA; Kottschade LA; Rowland KM; Dakhil SR; Nikcevich DA; Loprinzi CL
    Support Care Cancer; 2013 Apr; 21(4):1185-92. PubMed ID: 23150188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application and Clinical Value of Machine Learning-Based Cervical Cancer Diagnosis and Prediction Model in Adjuvant Chemotherapy for Cervical Cancer: A Single-Center, Controlled, Non-Arbitrary Size Case-Control Study.
    Wang Y; Shen L; Jin J; Wang G
    Contrast Media Mol Imaging; 2022; 2022():2432291. PubMed ID: 35821886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study.
    van Erning FN; Janssen-Heijnen MLG; Wegdam JA; Slooter GD; Wijsman JH; Vreugenhil A; Beijers TAJM; van de Poll-Franse LV; Lemmens VEPP
    Clin Colorectal Cancer; 2017 Sep; 16(3):195-203. PubMed ID: 27756521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study.
    Pappot H; Baeksted CW; Nissen A; Knoop A; Mitchell SA; Christensen J; Hjollund NH; Johansen C
    Breast Cancer; 2021 Sep; 28(5):1096-1099. PubMed ID: 33837509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
    Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
    Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
    Earl H; Hiller L; Vallier AL; Loi S; McAdam K; Hughes-Davies L; Rea D; Howe D; Raynes K; Higgins HB; Wilcox M; Plummer C; Mahler-Araujo B; Provenzano E; Chhabra A; Gasson S; Balmer C; Abraham JE; Caldas C; Hall P; Shinkins B; McCabe C; Hulme C; Miles D; Wardley AM; Cameron DA; Dunn JA
    Health Technol Assess; 2020 Aug; 24(40):1-190. PubMed ID: 32880572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study.
    Forsse D; Barbero ML; Werner HMJ; Woie K; Nordskar N; Berge Nilsen E; Ellstrøm Engh M; Vistad I; Rege A; Sævik-Lode M; Andreasen S; Haldorsen IS; Trovik J; Krakstad C
    Am J Obstet Gynecol; 2022 Jan; 226(1):90.e1-90.e20. PubMed ID: 34400137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL).
    Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Buono DL; Nathanson SD; Bovbjerg DH; Mandelblatt JS; Tsai WY; Jacobson JS; Hershman DL
    Breast Cancer Res Treat; 2016 Jul; 158(1):127-138. PubMed ID: 27287779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences.
    Hellerstedt-Börjesson S; Nordin K; Fjällskog ML; Rissanen R; Peterson M; Arving C
    Scand J Pain; 2018 Oct; 18(4):581-591. PubMed ID: 29949517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    Pain Manag Nurs; 2022 Aug; 23(4):532-540. PubMed ID: 34972658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
    Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
    Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study.
    Ma J; Pazo EE; Zou Z; Jin F
    Breast; 2020 Oct; 53():164-171. PubMed ID: 32836200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients.
    de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
    Cancer Nurs; 2006; 29(6):467-77. PubMed ID: 17135820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer.
    Son KL; Jung D; Lee KM; Yeom CW; Oh GH; Kim TY; Im SA; Lee KH; Spiegel D; Hahm BJ
    J Korean Med Sci; 2022 Feb; 37(5):e34. PubMed ID: 35132840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study.
    Galizia D; Milani A; Geuna E; Martinello R; Cagnazzo C; Foresto M; Longo V; Berchialla P; Solinas G; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Ballari AM; Aglietta M; Montemurro F
    Cancer Med; 2018 Sep; 7(9):4339-4344. PubMed ID: 30030895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine Learning Methods to Extract Documentation of Breast Cancer Symptoms From Electronic Health Records.
    Forsyth AW; Barzilay R; Hughes KS; Lui D; Lorenz KA; Enzinger A; Tulsky JA; Lindvall C
    J Pain Symptom Manage; 2018 Jun; 55(6):1492-1499. PubMed ID: 29496537
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.